Selected drug complications and treatment conflicts in the presence of coexistent diseases

Rheumatic Disease Clinics of North America

Volumn 25, Issue 3, 1999, Pages 745-777

  Vassilopoulos, D ^a   Camisa, C ^a   Strauss, R M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AURANOFIN; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DICLOFENAC; DIFLUNISAL; ETODOLAC; FENOPROFEN; GOLD; IBUPROFEN; INDOMETACIN; METHOTREXATE; METHYLPREDNISOLONE; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PHENYLBUTAZONE; PIROXICAM; PREDNISOLONE; SALAZOSULFAPYRIDINE; SULINDAC; TACROLIMUS; UNINDEXED DRUG;

CLINICAL PRACTICE; DRUG CHOICE; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY DISEASE; LIVER DISEASE; MALIGNANT NEOPLASTIC DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; SKIN DISEASE; TREATMENT PLANNING;

EID: 0032794694     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70096-X     Document Type: Article

References (232)